Summary from the original article
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands.
AI key points, how left, center and right framed this story, tone by side and loaded language are part of News.gg Premium.
Upgrade this serverThe Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands.
2 days ago · cbsnews.com · You are reading this one
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with popular drugs used for weight loss and diabetes, such as Ozempic
2 days ago · independent.co.uk
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with popular drugs used for weight loss and diabetes, such as Ozempic
2 days ago · inquirer.com
The Washington Post · 2 days ago
FDA tells GLP-1 makers to warn of potential vision loss side effectEuronews · 2 days ago
US drug watchdog orders new safety warnings for weight-loss drugs over potential risk of vision lossSky News · 2 days ago
FDA orders blindness risk warning on weight loss drugs
